Physician profile
Chi Zhang
NPI 1114372273
$4,008.31
in general payments reported to CMS, 2019-2025
18 companies · $1,852 in 2025
The $1,852 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $2,031 · 2025: $1,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,012 · Travel and Lodging: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,011.99 |
| Travel and Lodging | $996.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,457.62 | 2024-2025 | Aveir, Agilis, Jot Dx |
| Medtronic, INC. | $908.90 | 2023-2025 | Micra, Pulseselect, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $750.84 | 2024-2025 | Emblem Mri S-Icd, Acuity Steerable, Resonate El Icd Vr |
| Atricure, INC. | $142.33 | 2025 | Synergy Ablation System |
| Biosense Webster, INC. | $121.66 | 2024 | Carto 3 |
| Biotronik INC. | $95.32 | 2024-2025 | Renamic Neo |
| Cardiva Medical, INC. | $88.34 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Heartflow, INC. | $79.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $71.50 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.43 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $52.52 | 2024 | Xarelto |
| Pfizer INC. | $45.00 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $38.37 | 2024-2025 | Camzyos |
| Edwards Lifesciences Corporation | $27.26 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kestra Medical Technology Services, INC. | $22.90 | 2024 | Assure Wcd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $18.83 | 2024 | Arcalyst |
| Amgen INC. | $17.21 | 2025 | Repatha |
| Novo Nordisk INC | $17.11 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chi Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.